Erlotinib vs Vancomycin
Erlotinib vs Vancomycin: Overview
This comparison examines the pharmacological differences between Erlotinib and Vancomycin.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Vancomycin: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Vancomycin β 4-6 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Vancomycin β C66H75Cl2N9O24.
Molecular Weight: Erlotinib β 393.4380 g/mol; Vancomycin β 1449.2500 g/mol.
Type: Erlotinib β Small molecule; Vancomycin β Small molecule.